Since most cases of BLS-type DLBCL are linked to an activated B-cell immunophenotype with expression of BCL-6 and MUM-1/IRF-4, we hypothesized that tumor progenitor cells are activated B cells that colonize the bone marrow before neoplastic transformation. Here, IRF4 is linked to diffuse large B-cell lymphoma.